Xenios AG - a Fresenius Medical Care company

Xenios AG is a medical technology company based in Heilbronn, Germany, and is part of the Fresenius Medical Care Group. The company specializes in extracorporeal heart and lung support systems, developing advanced devices for extracorporeal membrane oxygenation (ECMO) therapy. Their flagship product, the Xenios console, integrates heart and lung assist therapies into a single system, allowing for minimally invasive, multi-organ support. The product portfolio includes the Novalung and Medos lines, which provide a range of solutions for heart and lung support. Novalung therapy enhances patient mobility and comfort during treatment, improving outcomes in intensive care settings. Xenios also offers clinical support and training through initiatives like the Xenios Campus, aimed at educating healthcare professionals on advanced therapies. The company serves hospitals and healthcare providers worldwide, focusing on critically ill patients with cardiac and pulmonary insufficiency.

• Employees 300
• Founded 2013
• Annual Revenue $20145000000